ad image

Diant Pharma

1 / 1
Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing
Lipid Nanoparticles

Feasibility Studies and cGMP Design Supporting Continuous Lipid Nanoparticle Manufacturing

Jim Ziogas

DIANT Pharma

PAO-05-24-CL-03May 30, 2024
The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles
mRNA–LNP Manufacturing

The Innovators Bringing Continuous Manufacturing to Lipid Nanoparticles

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

PAO-03-24-CL-08Mar 18, 2024
Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform
Lipid Nanoparticles

Facilitating Development and Scale-Up of Nanoparticle Drug Products with an End-to-End Adaptable Manufacturing Platform

Antonio Costa, Ph.D.

DIANT Pharma

PAO-10-23-CL-03Nov 01, 2023
DIANT Pharma
Continuous Processing

US Food and Drug Administration (FDA) Purchase the LiFT System from DIANT® Pharma INC.

DIANT Pharma

PR-M07-23-03Jul 31, 2023
Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution
Lipid Nanoparticles

Facilitating Lipid Nanoparticle Production with a Unique Continuous Manufacturing Solution

Antonio Costa, Ph.D.; William Pasek

DIANT Pharma

PAO-04-23-CL-05May 06, 2023
Lipid Nanoparticles: Transforming the Nanomedicines Market
Lipid Nanoparticles

Lipid Nanoparticles: Transforming the Nanomedicines Market

Antonio Costa, Ph.D.

DIANT Pharma

PAO-02-23-CL-01Feb 07, 2023
Innovating Nanoparticles for Pharmaceutical Applications
Nanoparticles

Innovating Nanoparticles for Pharmaceutical Applications

DIANT Pharma

PAO-02-22-R250-18Feb 24, 2022
1 / 1